KFB-18317-81416
5 vaccinations
8 coded responses
60 check-ins
8 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 303 / GA
- Registered
- 2021-03-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Registered in v-safe
-
2021-03-24
Dose 1 — Pfizer-BioNTech
- 2021-03-24
-
2021-03-25
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-26
Survey response — days 1–6 daily, dose 1MedDRA: Somnolence — Feeling: Fair · Fatigue or tirednessFree text: marked daytime drowsinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-27
Survey response — days 1–6 daily, dose 1MedDRA: Unevaluable event — Feeling: Good · Fatigue or tirednessFree text: want to nap a lotMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-07
- 2021-04-14
-
2021-04-19
Dose 2 — Pfizer-BioNTech
-
2021-04-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-05-17
-
2021-05-24
Survey response — day 35, dose 2MedDRA: Aphonia, Fatigue, Respiratory tract congestion — Feeling: FairFree text: loss of voice, light congestion, fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-31
- 2021-07-19
-
2021-10-18
Survey response — 6 months, dose 2MedDRA: Macular hole, Office visit, Retinal detachment, Surgery — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Detached retina, macular hole · Healthcare visit (other): Retina specialist and outpatient surgery x2MedDRA releases: 2024-11 · check-in free text available
-
2021-10-18
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-10-22
- 2021-10-27
- 2021-11-01
-
2021-11-04
Call successfulParticipant prefers to complete VAERS report online
-
2021-11-15
Dose 3 — Pfizer-BioNTech
-
2021-11-16
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-17
- 2021-11-18
- 2021-11-19
- 2021-11-20
- 2021-11-21
- 2021-11-22
- 2021-11-29
- 2021-12-06
- 2021-12-13
-
2021-12-20
Survey response — day 35, dose 3MedDRA: Office visit, Retinal detachment, Surgery — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: 3rd surgery for persistent detached retina · Healthcare visit (other): under weekly retinal specialist careMedDRA releases: 2024-11 · check-in free text available
-
2021-12-20
Report sent to call center — day 35, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-12-22
- 2021-12-28
- 2022-02-14
- 2022-05-16
-
2022-05-26
Dose 4 — Pfizer-BioNTech
- 2022-05-26
-
2022-05-27
Survey response — days 1–6 daily, dose 4MedDRA: Injection site warmth, Pain in extremity — Feeling: Good · Site: PainFree text: injection site warm, arm soreMedDRA releases: 2024-11 · check-in free text available
- 2022-05-28
- 2022-05-29
- 2022-05-30
- 2022-05-31
- 2022-06-01
- 2022-06-02
- 2022-06-09
- 2022-06-16
- 2022-06-23
- 2022-06-30
-
2022-07-07
Survey response — day 42, dose 4MedDRA: Ageusia, Anosmia, COVID-19, Decreased appetite, Diarrhoea, Ear congestion, Fatigue, Headache, Nasal congestion, Nausea, Pyrexia, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid - ear, nose, chest congestion; nausea; diarrhea; headache; low grade fever; fatigue; loss of appetite; loss of smell; loss of tasteMedDRA releases: 2024-11 · check-in free text available
-
2022-08-26
Survey response — 3 months, dose 4MedDRA: Pre-existing disease, Unevaluable event, Uterine dilation and curettage — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Outpatient surgery for D&C; continued treatment for retinal detachment · Healthcare visit (other): See aboveMedDRA releases: 2024-11 · check-in free text available
-
2022-08-26
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2022-08-26
- 2022-08-26
-
2022-10-30
Dose 5 — Pfizer-BioNTechCo-administered: Flu
- 2022-11-07
- 2022-11-13
- 2022-11-20
- 2022-11-27
- 2022-12-04
- 2022-12-11
- 2023-01-29
- 2023-04-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Pfizer-BioNTech | |
| 2 | 2021-04-19 | Pfizer-BioNTech | |
| 3 | 2021-11-15 | Pfizer-BioNTech | No |
| 4 | 2022-05-26 | Pfizer-BioNTech | No |
| 5 | 2022-10-30 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-18 | Successful 2021-11-04 |
Participant prefers to complete VAERS report online |
| 2021-12-20 | Unsuccessful | |
| 2022-08-26 | Unsuccessful |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): marked daytime drowsiness
Systemic reaction (other): want to nap a lot
Release 8 — day 35, dose 2
Symptoms: loss of voice, light congestion, fatigue
Release 10 — 6 months, dose 2
Symptoms: Detached retina, macular hole
Healthcare visit (other): Retina specialist and outpatient surgery x2
Release 10 — day 35, dose 3
Symptoms: 3rd surgery for persistent detached retina
Healthcare visit (other): under weekly retinal specialist care
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): injection site warm, arm sore
Release 12 — day 42, dose 4
Symptoms: Covid - ear, nose, chest congestion; nausea; diarrhea; headache; low grade fever; fatigue; loss of appetite; loss of smell; loss of taste
Release 12 — 3 months, dose 4
Symptoms: Outpatient surgery for D&C; continued treatment for retinal detachment
Healthcare visit (other): See above
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Surgery | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Aphonia | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Ear congestion | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Macular hole | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Retinal detachment | · | · | ✓ |
| SD | Surgery | · | · | ✓ |
| SD | Uterine dilation and curettage | · | · | ✓ |
| SRO | Injection site warmth | · | · | ✓ |
| SRO | Pain in extremity | · | · | ✓ |
| SRO | Somnolence | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release